Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)

Company Overview - China SXT Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (TCMPs) and TCM Homologous Supplements (TCMHS) [7] - The company was founded in 2005 and is headquartered in Taizhou City, Jiangsu Province, China [7] Offering Details - Univest Securities, LLC announced the closing of a registered direct offering of approximately $10 million for China SXT Pharmaceuticals [1] - The offering involved the sale of 66,666,666 Class A ordinary shares at a purchase price of $0.15 per share [2] - The gross proceeds from the offering were approximately $10 million, with Univest acting as the sole placement agent [3] Regulatory Compliance - The registered direct offering was made under a shelf registration statement on Form F-3, which became effective on December 1, 2025 [4]